Richard J. Ablin, PhD
Research Professor

Contact Information:

• Immunobiology, College of Medicine Room 6107
• Phone: 626-7755
• Fax: 626-2100
• Email: ablinrj@email.arizona.edu
• Faculty Member's BIO5 Webpage

Education:

• State University of New York at Buffalo, 1967.

Research:

Immunobiology of Cancer
Studies are directed toward: a) ascertaining the role of the inter- and/or intratumoural microenvironment (milieu) in contributing to the development and progression of cancer; b) the differentiation of latent (indolent) cancer from one that is aggressive and clinically important and should be treated and c) development of response criteria (biological markers) to evaluate the effectiveness of new therapeutic regimens and/or agents.

 

Publications:

• Davies G, Ablin RJ, Mason MD, Jiang WG. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer. J. Exptl. Therapeut. Oncol., 6:257-264, 2007.
• Tokar EJ, Ablin RJ, Webber MM. Retinoids, vitamin D, invasion and metastasis. Current Oncol., 13:198-200, 2006.
• Tokar EJ, Ancrile BB, Ablin RJ, Webber MM. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer. J. Exptl. Therapeut. Oncol., 5:323-333, 2006
• Rivette AS, Tokar EJ, Williams DE, Mackenzie CD, Ablin RJ, Webber MM. Selection of cell lines with enhanced invasive phenotype from xenografts of the human prostate cancer cell line WPE1-NB26. J. Exptl. Therapeut. Oncol., 5:111-123, 2005.
• Szabo, KA, Ablin, RJ and Singh G. Matrix metalloproteinases and the immune response. Clin. Appl. Immunol. Rev., 4:295-319, 2004.

Peer-reviewed publications

Click here to see a listing of Peer-reviewed publications